![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2023
Anzahl der Publikationen: 1
2023
Moosburner, Marie; Alibegovic, Lamija; Hasselmann, Korbinian 
ORCID: https://orcid.org/0009-0000-5907-6841; Gaiderov, Anton; Hildebrand, Johannes; Philippou‐Massier, Julia; Blum, Helmut; Fischer, Luca ORCID: https://orcid.org/0000-0003-2444-416X; Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249 und Silkenstedt, Elisabeth ORCID: https://orcid.org/0000-0003-2676-0860
(2023):
Combined treatment with crizotinib and temsirolimus is an effective strategy in mantle cell lymphoma and can overcome acquired resistance to temsirolimus.
In: Hematological Oncology, Bd. 41, Nr. 5: S. 858-868
[PDF, 1MB]
ORCID: https://orcid.org/0009-0000-5907-6841; Gaiderov, Anton; Hildebrand, Johannes; Philippou‐Massier, Julia; Blum, Helmut; Fischer, Luca ORCID: https://orcid.org/0000-0003-2444-416X; Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249 und Silkenstedt, Elisabeth ORCID: https://orcid.org/0000-0003-2676-0860
(2023):
Combined treatment with crizotinib and temsirolimus is an effective strategy in mantle cell lymphoma and can overcome acquired resistance to temsirolimus.
In: Hematological Oncology, Bd. 41, Nr. 5: S. 858-868
[PDF, 1MB]